Cyp2a6 and gabra2 gene polymorphisms are associated with dexmedetomidine drug response

HIGHLIGHTS

• who: CYP and colleagues from the Department of Anesthesiology, Third Xiangya Hospital, Central South University, Changsha, China, Hunan Cancer Hospital, The have published the research: CYP2A6 and GABRA2 Gene Polymorphisms are Associated With Dexmedetomidine Drug Response, in the Journal: (JOURNAL)
• what: The aim of the study is to explore the association between dexmedetomidine response and gene polymorphisms related to drug-metabolizing enzymes and drug response (CYP2A6, UGT2B10, UGT1A4, ADRA2A, ADRA2B, ADRA2C, GABRA1, GABRB2, and GLRA1).
• how: In this study patients with a Ramsy score of at least four within 20 min were considered . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.